Loading...
The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada
BACKGROUND: Patient reported outcome measures (PROMs) and minimal clinically important differences (MCIDs) are included in Canada’s Common Drug Review (CDR) process to approve new drugs. Often, the measures report on the health-related quality of life (HRQoL), but can also describe the symptoms, eff...
Na minha lista:
| Udgivet i: | Health Qual Life Outcomes |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6322322/ https://ncbi.nlm.nih.gov/pubmed/30616654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-018-1070-0 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|